Morbidities involving the skin, liver, and gut after nonmyeloablative conditioning compared with myeloablative conditioning. Shown are proportions of patients who experienced no morbidity and morbidity grades 1, 2, and 3 at different time points during the 12 months after transplantation. (A) Skin; (B) liver; (C) gut; and (D) overall.